| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37449-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50443-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50293-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35066-1mg | |||
| Carrier-Free | NBP2-35066-100ug | |||
| Carrier-Free | NBP2-35066-500ug | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor Plus 488 | NB100-2658AFP488 | |||
| Alexa Fluor Plus 555 | NB100-2658AFP555 | |||
| Alexa Fluor Plus 594 | NB100-2658AFP594 | |||
| Alexa Fluor Plus 647 | NB100-2658AFP647 | |||
| Alexa Fluor Plus 680 | NB100-2658AFP680 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2658-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-52438-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50468-0.025ml | |||
![Immunocytochemistry/Immunofluorescence: CD19 Antibody (2E2) [NBP2-22198] - Immunofluorescence analysis of HL-60(left) and K562 (right) cells using CD19 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye.](http://images.novusbio.com/fullsize/CD19-Antibody-2E2-Immunocytochemistry-Immunofluorescence-NBP2-22198-img0002.jpg "Immunocytochemistry/Immunofluorescence: CD19 Antibody (2E2) [NBP2-22198] - Immunofluorescence analysis of HL-60(left) and K562 (right) cells using CD19 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye.")
![Flow Cytometry: CD19 Antibody (2E2) [NBP2-22198] - Flow cytometric analysis of Raji cells using CD19 mouse mAb (green) and negative control (purple).](http://images.novusbio.com/fullsize/CD19-Antibody-2E2-Flow-Cytometry-NBP2-22198-img0001.jpg)
![Western Blot: RAG1 Antibody (1D9) [NBP2-37449] - Western blot analysis using RAG1 mAb against HEK293 (1) and RAG1 (AA: 818-868)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/RAG1-Antibody-1D9-Western-Blot-NBP2-37449-img0003.jpg "Western Blot: RAG1 Antibody (1D9) [NBP2-37449] - Western blot analysis using RAG1 mAb against HEK293 (1) and RAG1 (AA: 818-868)-hIgGFc transfected HEK293 (2) cell lysate.")
![Western Blot: RAG1 Antibody (1D9) [NBP2-37449] - Western blot analysis using RAG1 mAb against human RAG1 recombinant protein. (Expected MW is 31.6 kDa)](http://images.novusbio.com/fullsize/RAG1-Antibody-1D9-Western-Blot-NBP2-37449-img0002.jpg)
![ELISA: RAG1 Antibody (1D9) [NBP2-37449] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/RAG1-Antibody-1D9-ELISA-NBP2-37449-img0001.jpg)
![Western Blot: SLA2 Antibody (Z30P1F12/F4) [NBP2-50293] - Analysis of SLA2 in transfected Jurkat cell lysate.](http://images.novusbio.com/fullsize/SLA2-Antibody-Z30P1F12-F4-Western-Blot-NBP2-50293-img0002.jpg "Western Blot: SLA2 Antibody (Z30P1F12/F4) [NBP2-50293] - Analysis of SLA2 in transfected Jurkat cell lysate.")
![Immunohistochemistry: SLA2 Antibody (Z30P1F12/F4) [NBP2-50293] - Analysis of pancreatic adenocarcinoma tissue using anti-SLA2 [Z30P1F12 F4]. Cytoplasmic staining was observed.](http://images.novusbio.com/fullsize/SLA2-Antibody-Z30P1F12-F4-Immunohistochemistry-NBP2-50293-img0001.jpg)
![SDS-Page: Mouse GM-CSF Protein [NBP2-35066]](http://images.novusbio.com/fullsize/Mouse-GM-CSF-Protein-SDS-Page-NBP2-35066-img0001.jpg "SDS-Page: Mouse GM-CSF Protein [NBP2-35066]")
![Western Blot: CD200/OX2 Antibody (6E8B11) [NBP2-52438] - 1: Western blot analysis using CD200 mAb against human CD200 (AA: Extra(56-257)) recombinant protein. (Expected MW is 48.4 kDa)](http://images.novusbio.com/fullsize/CD200-OX2-Antibody-6E8B11-Western-Blot-NBP2-52438-img0001.jpg "Western Blot: CD200/OX2 Antibody (6E8B11) [NBP2-52438] - 1: Western blot analysis using CD200 mAb against human CD200 (AA: Extra(56-257)) recombinant protein. (Expected MW is 48.4 kDa)")
![Western Blot: CD200/OX2 Antibody (6E8B11) [NBP2-52438] - Analysis using CD200 mAb against HEK293 (1) and CD200 (AA: Extra(56-257))-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CD200-OX2-Antibody-6E8B11-Western-Blot-NBP2-52438-img0002.jpg)
![ELISA: CD200/OX2 Antibody (6E8B11) [NBP2-52438] - Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng)](http://images.novusbio.com/fullsize/CD200-OX2-Antibody-6E8B11-ELISA-NBP2-52438-img0003.jpg)
![Western Blot: BOB1 Antibody (OTI1E11) - Azide and BSA Free [NBP2-71223] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BOB1.](http://images.novusbio.com/fullsize/BOB1-Antibody-OTI1E11-Azide-and-BSA-Free-Western-Blot-NBP2-71223-img0002.jpg "Western Blot: BOB1 Antibody (OTI1E11) - Azide and BSA Free [NBP2-71223] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY BOB1.")
![Western Blot: BOB1 Antibody (OTI1E11) - Azide and BSA Free [NBP2-71223] - Analysis of extracts (15ug) from 9 Human tissue. (1: Testis; 2: Uterus; 3: Breast; 4: Brain; 5: Liver; 6: Ovary; 7: Thyroid gland; 8: colon: 9:Spleen)](http://images.novusbio.com/fullsize/BOB1-Antibody-OTI1E11-Azide-and-BSA-Free-Western-Blot-NBP2-71223-img0001.jpg)
![Western Blot: IL-12 p70/IL-12A Antibody (OTI2A8) - Azide and BSA Free [NBP2-71031] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IL-12 p70.](http://images.novusbio.com/fullsize/IL-12-p70-IL-12A-Antibody-OTI2A8-Azide-and-BSA-Free-Western-Blot-NBP2-71031-img0001.jpg "Western Blot: IL-12 p70/IL-12A Antibody (OTI2A8) - Azide and BSA Free [NBP2-71031] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY IL-12 p70.")
![Immunohistochemistry: IL-12 p70/IL-12A Antibody (OTI2A8) - Azide and BSA Free [NBP2-71031] - Analysis of Carcinoma of Human lung tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)](http://images.novusbio.com/fullsize/IL-12-p70-IL-12A-Antibody-OTI2A8-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71031-img0002.jpg)
![Western Blot: NCAM-1/CD56 Antibody (OTI1B9) - Azide and BSA Free [NBP2-72892] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NCAM1.](http://images.novusbio.com/fullsize/NCAM-1-CD56-Antibody-OTI1B9-Azide-and-BSA-Free-Western-Blot-NBP2-72892-img0001.jpg "Western Blot: NCAM-1/CD56 Antibody (OTI1B9) - Azide and BSA Free [NBP2-72892] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NCAM1.")
![Flow Cytometry: BAFF/BLyS/TNFSF13B Antibody (5A8) [NBP1-97639] - HEK 293T cells were mock transfected (thin line) or transfected with an expression plasmid enabling surface expression of the extracellular domain of mouse BAFF (thick line). Cells (5 x 10^5) were incubated on ice for 30 min in 50ul FACS buffer (PBS, 5% fetal calf serum, 0.02% sodium azide) containing 1ug/ml of MAb to BAFF (mouse) (5A8). After washing in FACS buffer, R-PE-conjugated antibody to rat IgG was added. Cells were incubated on ice for 30 min, washed and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/TNFSF13B-Antibody-5A8-Flow-Cytometry-NBP1-97639-img0001.jpg "Flow Cytometry: BAFF/BLyS/TNFSF13B Antibody (5A8) [NBP1-97639] - HEK 293T cells were mock transfected (thin line) or transfected with an expression plasmid enabling surface expression of the extracellular domain of mouse BAFF (thick line). Cells (5 x 10^5) were incubated on ice for 30 min in 50ul FACS buffer (PBS, 5% fetal calf serum, 0.02% sodium azide) containing 1ug/ml of MAb to BAFF (mouse) (5A8). After washing in FACS buffer, R-PE-conjugated antibody to rat IgG was added. Cells were incubated on ice for 30 min, washed and then analyzed by flow cytometry.")